Literature DB >> 28472223

Immune checkpoint-associated cardiotoxicity: case report with systematic review of literature.

A Chauhan1, G Burkeen1, J Houranieh2, S Arnold1, L Anthony1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28472223     DOI: 10.1093/annonc/mdx213

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations.

Authors:  Emanuel Raschi; Igor Diemberger; Benilde Cosmi; Fabrizio De Ponti
Journal:  Intern Emerg Med       Date:  2017-09-23       Impact factor: 3.397

2.  [Curing cancer and protecting the heart : Challenges in cardio-oncology in the era of modern tumor treatment].

Authors:  C Hohmann; S Baldus; R Pfister
Journal:  Herz       Date:  2019-04       Impact factor: 1.443

3.  Immune Check Point Inhibitors in Cancer Therapy: Beware of "Friendly Fire" Effect.

Authors:  Anuhya Kommalapati; Shanaz Sikder; Sri Harsha Tella
Journal:  Res Rev J Hosp Clin Pharm       Date:  2017-06-08

4.  Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer.

Authors:  Kalyan R Chitturi; Jiaqiong Xu; Raquel Araujo-Gutierrez; Arvind Bhimaraj; Ashrith Guha; Imad Hussain; Mahwash Kassi; Eric H Bernicker; Barry H Trachtenberg
Journal:  JACC CardioOncol       Date:  2019-12-17

5.  Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Cohort Study with competing risk analysis.

Authors:  Jiandong Zhou; Sharen Lee; Ishan Lakhani; Lei Yang; Tong Liu; Yuhui Zhang; Yunlong Xia; Wing Tak Wong; Kelvin King Hei Bao; Ian Chi Kei Wong; Gary Tse; Qingpeng Zhang
Journal:  Cardiooncology       Date:  2022-03-17

Review 6.  Mechanism and Management of Cancer Chemotherapy-Induced Atherosclerosis.

Authors:  Mikio Mukai; Keiko Komori; Toru Oka
Journal:  J Atheroscler Thromb       Date:  2018-09-14       Impact factor: 4.928

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.